US Stock MarketDetailed Quotes

MAIA MAIA Biotechnology

Watchlist
  • 3.060
  • +0.130+4.44%
Trading May 1 15:22 ET
62.98MMarket Cap-2053P/E (TTM)

MAIA Biotechnology Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
-34.70%7.15M
-34.70%7.15M
-56.59%6.1M
12.22%9.15M
-26.30%7.59M
3.56%10.95M
3.56%10.95M
--14.06M
--8.15M
--10.29M
-Cash and cash equivalents
-34.70%7.15M
-34.70%7.15M
-56.59%6.1M
12.22%9.15M
-26.30%7.59M
3.56%10.95M
3.56%10.95M
--14.06M
--8.15M
--10.29M
Receivables
-52.22%144.68K
-52.22%144.68K
-55.18%114.43K
90.41%386.83K
--348.38K
593.42%302.79K
593.42%302.79K
--255.31K
--203.16K
----
-Other receivables
-52.22%144.68K
-52.22%144.68K
-55.18%114.43K
90.41%386.83K
--348.38K
593.42%302.79K
593.42%302.79K
--255.31K
--203.16K
----
Other current assets
-51.53%268.68K
-51.53%268.68K
-10.15%414.12K
-5.12%243.33K
70.00%398.87K
916.41%554.32K
916.41%554.32K
--460.92K
--256.47K
--234.63K
Total current assets
-35.94%7.56M
-35.94%7.56M
-55.12%6.63M
13.55%9.78M
-20.84%8.33M
10.64%11.81M
10.64%11.81M
--14.78M
--8.61M
--10.53M
Non current assets
Non current deferred assets
--0
--0
--365.14K
-57.32%489.65K
-19.26%737.69K
-67.59%211.2K
-67.59%211.2K
--0
--1.15M
--913.68K
Other non current assets
0.00%2.8K
0.00%2.8K
0.00%2.8K
0.00%2.8K
0.00%2.8K
-10.31%2.8K
-10.31%2.8K
--2.8K
--2.8K
--2.8K
Total non current assets
-98.69%2.8K
-98.69%2.8K
13,040.71%367.94K
-57.18%492.45K
-19.20%740.49K
-67.31%214K
-67.31%214K
--2.8K
--1.15M
--916.48K
Total assets
-37.06%7.57M
-37.06%7.57M
-52.64%7M
5.22%10.27M
-20.71%9.07M
6.13%12.02M
6.13%12.02M
--14.78M
--9.76M
--11.44M
Liabilities
Current liabilities
Payables
40.59%1.64M
40.59%1.64M
20.31%1.23M
48.73%1.55M
25.95%1.13M
21.36%1.17M
21.36%1.17M
--1.02M
--1.04M
--895.11K
-accounts payable
40.59%1.64M
40.59%1.64M
20.31%1.23M
48.73%1.55M
25.95%1.13M
21.36%1.17M
21.36%1.17M
--1.02M
--1.04M
--895.11K
Current accrued expenses
67.24%1.69M
67.24%1.69M
237.83%2.1M
-1.14%1.15M
43.00%1.23M
46.30%1.01M
46.30%1.01M
--622.96K
--1.16M
--859.58K
Current deferred liabilities
----
----
----
----
----
----
----
--32.59K
--114.33K
--114.33K
Current liabilities
51.03%4.94M
51.03%4.94M
68.95%4.15M
5.66%3.27M
54.94%3.77M
52.33%3.27M
52.33%3.27M
--2.46M
--3.1M
--2.43M
Non current liabilities
Derivative product liabilities
777.22%2.15M
777.22%2.15M
--103.41K
--121.6K
--224.4K
--245.34K
--245.34K
----
----
----
Total non current liabilities
777.22%2.15M
777.22%2.15M
--103.41K
--121.6K
--224.4K
--245.34K
--245.34K
--0
--0
--0
Total liabilities
101.73%7.09M
101.73%7.09M
73.16%4.25M
9.58%3.39M
64.17%3.99M
63.76%3.51M
63.76%3.51M
--2.46M
--3.1M
--2.43M
Shareholders'equity
Share capital
55.02%1.7K
55.02%1.7K
25.75%1.38K
62.11%1.37K
38.54%1.1K
44.59%1.1K
44.59%1.1K
--1.1K
--842
--794
-common stock
55.02%1.7K
55.02%1.7K
25.75%1.38K
62.11%1.37K
38.54%1.1K
44.59%1.1K
44.59%1.1K
--1.1K
--842
--794
-Preferred stock
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Retained earnings
-44.73%-63.98M
-44.73%-63.98M
-47.67%-57.72M
-50.32%-52.85M
-51.72%-48.32M
-55.45%-44.21M
-55.45%-44.21M
---39.09M
---35.16M
---31.85M
Paid-in capital
22.27%64.47M
22.27%64.47M
17.58%60.51M
42.86%59.75M
30.76%53.43M
40.17%52.73M
40.17%52.73M
--51.47M
--41.82M
--40.86M
Gains losses not affecting retained earnings
-1.80%-16.26K
-1.80%-16.26K
15.26%-43.77K
-525.04%-25.91K
-1,568.56%-25.27K
---15.97K
---15.97K
---51.65K
---4.15K
--1.72K
Total stockholders'equity
-94.39%477.51K
-94.39%477.51K
-77.71%2.75M
3.19%6.87M
-43.61%5.08M
-7.33%8.51M
-7.33%8.51M
--12.33M
--6.66M
--9.01M
Total equity
-94.39%477.51K
-94.39%477.51K
-77.71%2.75M
3.19%6.87M
-43.61%5.08M
-7.33%8.51M
-7.33%8.51M
--12.33M
--6.66M
--9.01M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Assets
Current assets
Cash, cash equivalents and short term investments -34.70%7.15M-34.70%7.15M-56.59%6.1M12.22%9.15M-26.30%7.59M3.56%10.95M3.56%10.95M--14.06M--8.15M--10.29M
-Cash and cash equivalents -34.70%7.15M-34.70%7.15M-56.59%6.1M12.22%9.15M-26.30%7.59M3.56%10.95M3.56%10.95M--14.06M--8.15M--10.29M
Receivables -52.22%144.68K-52.22%144.68K-55.18%114.43K90.41%386.83K--348.38K593.42%302.79K593.42%302.79K--255.31K--203.16K----
-Other receivables -52.22%144.68K-52.22%144.68K-55.18%114.43K90.41%386.83K--348.38K593.42%302.79K593.42%302.79K--255.31K--203.16K----
Other current assets -51.53%268.68K-51.53%268.68K-10.15%414.12K-5.12%243.33K70.00%398.87K916.41%554.32K916.41%554.32K--460.92K--256.47K--234.63K
Total current assets -35.94%7.56M-35.94%7.56M-55.12%6.63M13.55%9.78M-20.84%8.33M10.64%11.81M10.64%11.81M--14.78M--8.61M--10.53M
Non current assets
Non current deferred assets --0--0--365.14K-57.32%489.65K-19.26%737.69K-67.59%211.2K-67.59%211.2K--0--1.15M--913.68K
Other non current assets 0.00%2.8K0.00%2.8K0.00%2.8K0.00%2.8K0.00%2.8K-10.31%2.8K-10.31%2.8K--2.8K--2.8K--2.8K
Total non current assets -98.69%2.8K-98.69%2.8K13,040.71%367.94K-57.18%492.45K-19.20%740.49K-67.31%214K-67.31%214K--2.8K--1.15M--916.48K
Total assets -37.06%7.57M-37.06%7.57M-52.64%7M5.22%10.27M-20.71%9.07M6.13%12.02M6.13%12.02M--14.78M--9.76M--11.44M
Liabilities
Current liabilities
Payables 40.59%1.64M40.59%1.64M20.31%1.23M48.73%1.55M25.95%1.13M21.36%1.17M21.36%1.17M--1.02M--1.04M--895.11K
-accounts payable 40.59%1.64M40.59%1.64M20.31%1.23M48.73%1.55M25.95%1.13M21.36%1.17M21.36%1.17M--1.02M--1.04M--895.11K
Current accrued expenses 67.24%1.69M67.24%1.69M237.83%2.1M-1.14%1.15M43.00%1.23M46.30%1.01M46.30%1.01M--622.96K--1.16M--859.58K
Current deferred liabilities ------------------------------32.59K--114.33K--114.33K
Current liabilities 51.03%4.94M51.03%4.94M68.95%4.15M5.66%3.27M54.94%3.77M52.33%3.27M52.33%3.27M--2.46M--3.1M--2.43M
Non current liabilities
Derivative product liabilities 777.22%2.15M777.22%2.15M--103.41K--121.6K--224.4K--245.34K--245.34K------------
Total non current liabilities 777.22%2.15M777.22%2.15M--103.41K--121.6K--224.4K--245.34K--245.34K--0--0--0
Total liabilities 101.73%7.09M101.73%7.09M73.16%4.25M9.58%3.39M64.17%3.99M63.76%3.51M63.76%3.51M--2.46M--3.1M--2.43M
Shareholders'equity
Share capital 55.02%1.7K55.02%1.7K25.75%1.38K62.11%1.37K38.54%1.1K44.59%1.1K44.59%1.1K--1.1K--842--794
-common stock 55.02%1.7K55.02%1.7K25.75%1.38K62.11%1.37K38.54%1.1K44.59%1.1K44.59%1.1K--1.1K--842--794
-Preferred stock --0--0--0--0--0--0--0--0--0--0
Retained earnings -44.73%-63.98M-44.73%-63.98M-47.67%-57.72M-50.32%-52.85M-51.72%-48.32M-55.45%-44.21M-55.45%-44.21M---39.09M---35.16M---31.85M
Paid-in capital 22.27%64.47M22.27%64.47M17.58%60.51M42.86%59.75M30.76%53.43M40.17%52.73M40.17%52.73M--51.47M--41.82M--40.86M
Gains losses not affecting retained earnings -1.80%-16.26K-1.80%-16.26K15.26%-43.77K-525.04%-25.91K-1,568.56%-25.27K---15.97K---15.97K---51.65K---4.15K--1.72K
Total stockholders'equity -94.39%477.51K-94.39%477.51K-77.71%2.75M3.19%6.87M-43.61%5.08M-7.33%8.51M-7.33%8.51M--12.33M--6.66M--9.01M
Total equity -94.39%477.51K-94.39%477.51K-77.71%2.75M3.19%6.87M-43.61%5.08M-7.33%8.51M-7.33%8.51M--12.33M--6.66M--9.01M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg